World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Biology and Biochemistry 66 8440 7791 222 205 189 31188

Daniel S. Peeper publications per year

The chart shows the history of publications by Daniel S. Peeper between 1987 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Daniel S. Peeper published across 40 years, from 1987 to 2026, averaging 7.8 papers a year. Output peaked at 93 publications in 2023. 23 of the 310 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1987 to 2026. Vertical axis: number of publications, 0 to 93. Peak 93 publications in 2023. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 1 publication 1993: 4 publications 1994: 1 publication 1995: 4 publications 1996: 0 publications 1997: 3 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 4 publications 2002: 2 publications 2003: 0 publications 2004: 1 publication 2005: 3 publications 2006: 4 publications 2007: 1 publication 2008: 10 publications 2009: 6 publications 2010: 6 publications 2011: 8 publications 2012: 1 publication 2013: 7 publications 2014: 12 publications 2015: 15 publications 2016: 8 publications 2017: 14 publications 2018: 13 publications 2019: 12 publications 2020: 15 publications 2021: 13 publications 2022: 9 publications 2023: 93 publications 2024: 16 publications 2025: 22 publications 2026: 1 publication
1987 2026

310 publications in total across all disciplines

View publications per year as a table
Daniel S. Peeper: publications per year, 1987 to 2026
Year Publications
1987 1
1988 0
1989 0
1990 0
1991 0
1992 1
1993 4
1994 1
1995 4
1996 0
1997 3
1998 0
1999 0
2000 0
2001 4
2002 2
2003 0
2004 1
2005 3
2006 4
2007 1
2008 10
2009 6
2010 6
2011 8
2012 1
2013 7
2014 12
2015 15
2016 8
2017 14
2018 13
2019 12
2020 15
2021 13
2022 9
2023 93
2024 16
2025 22
2026 1
Total 310
Download as CSV

Daniel S. Peeper publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Daniel S. Peeper sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. The highlighted bar, 187–196 publications, is where this scientist sits. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

This scientist: 189 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists This scientist
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787 189
197–206 840
207–216 733
217–226 708
227–236 651
237–246 605
247–256 510
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Daniel S. Peeper D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel S. Peeper sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. The highlighted bar, 66–67 D-Index, is where this scientist sits. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists This scientist
40–41 80
42–43 183
44–45 316
46–47 504
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235
58–59 1,253
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897 66
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Research.com Recognitions

  • 2016 - Member of Academia Europaea
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Daniel S. Peeper is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands and has a research focus that spans medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their work concentrates heavily on oncology, molecular biology, immunology, cancer research, and pulmonary and respiratory medicine. This multidisciplinary approach is reflected in numerous publications and collaborations.

The scientist's research covers key topics such as cancer immunotherapy and biomarkers, CAR-T cell therapy research, immunotherapy and immune responses, immune cell function and interaction, immune cells in cancer, RNA modifications and cancer, and melanoma and MAPK pathways.

Their publication record includes articles in high-impact journals such as Nature, Nature Communications, Nature Medicine, Science, Molecular Cell, and bioRxiv. Some of the notable recent papers authored or co-authored by Daniel S. Peeper include:

  • B cells and tertiary lymphoid structures promote immunotherapy response (2020, Nature)
  • The human tumor microbiome is composed of tumor type-specific intracellular bacteria (2020, Science)
  • Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma (2021, Nature Medicine)
  • Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma (2021, Nature Communications)
  • Rational Cancer Treatment Combinations: An Urgent Clinical Need (2020, Molecular Cell)

Daniel S. Peeper collaborates frequently with a group of co-authors that includes Oscar Krijgsman, David W. Vredevoogd, Maarten Altelaar, Christian U. Blank, and Maarten A. Ligtenberg. These partnerships have contributed to a range of publications that reinforce their research presence across various subfields and topics.

Frequent publication venues where their work appears include bioRxiv (Cold Spring Harbor Laboratory), Nature, Nature Communications, Journal for ImmunoTherapy of Cancer, and Cancer Research, indicating a consistent output in both preprint and peer-reviewed literature.

Throughout their career, Daniel S. Peeper has been involved extensively in oncology-related research, with a special emphasis on cancer immunotherapy and biomarkers. Their work often intersects molecular biology and immunology aspects pertinent to cancer progression and therapy.

Awards recognizing their contributions include membership in the Academia Europaea since 2016 and membership in the European Molecular Biology Organization (EMBO).

Best Publications

  • BRAFE600-associated senescence-like cell cycle arrest of human naevi

    Chrysiis Michaloglou;Liesbeth C. W. Vredeveld;Maria S. Soengas;Christophe Denoyelle

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • The essence of senescence

    Thomas Kuilman;Chrysiis Michaloglou;Wolter J. Mooi;Daniel S. Peeper

  • Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network

    Thomas Kuilman;Chrysiis Michaloglou;Liesbeth C.W. Vredeveld;Sirith Douma

  • The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    Deborah Nejman;Ilana Livyatan;Garold Fuks;Nancy Gavert

  • Senescence-messaging secretome: SMS-ing cellular stress

    Thomas Kuilman;Daniel S. Peeper

  • Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB

    Sirith Douma;Theo van Laar;John Zevenhoven;Ralph Meuwissen

  • The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

    Benjamin D. Rowland;René Bernards;Daniel S. Peeper

  • Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

    Christian U. Blank;Elisa A. Rozeman;Lorenzo F. Fanchi;Karolina Sikorska

  • A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

    Joanna Kaplon;Liang Zheng;Katrin Meissl;Barbara Chaneton

  • KLF4, p21 and context-dependent opposing forces in cancer.

    Benjamin D. Rowland;Daniel S. Peeper

  • Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.

    Judith Müller;Oscar Krijgsman;Jennifer Tsoi;Lidia Robert

  • Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Annette T. Byrne;Denis G. Alférez;Frédéric Amant;Daniela Annibali

  • Cell cycle-specific association of E2F with the p130 E1A-binding protein.

    D Cobrinik;P Whyte;D S Peeper;T Jacks

  • Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein

    Daniel S. Peeper;Daniel S. Peeper;Todd M. Upton;Mohamed H. Ladha;Elizabeth Neuman

  • Oncogene-induced cell senescence--halting on the road to cancer.

    W J Mooi;D S Peeper

  • Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

    Elisa A Rozeman;Alexander M Menzies;Alexander C J van Akkooi;Chandra Adhikari

  • Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

    Fleur Weeber;Marc van de Wetering;Marlous Hoogstraat;Krijn K Dijkstra

  • The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

    Susanne Schlisio;Rajappa S. Kenchappa;Liesbeth C.W. Vredeveld;Rani E. George

  • Cellular senescence in vivo: a barrier to tumorigenesis.

    Alexandre Prieur;Daniel S Peeper

Frequent Co-Authors

Christian U. Blank
Christian U. Blank Antoni van Leeuwenhoek Hospital
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Ton N. M. Schumacher
Ton N. M. Schumacher Antoni van Leeuwenhoek Hospital
David J. Adams
David J. Adams Wellcome Sanger Institute
René Bernards
René Bernards Antoni van Leeuwenhoek Hospital
Ultan McDermott
Ultan McDermott AstraZeneca (United Kingdom)
John B. A. G. Haanen
John B. A. G. Haanen Antoni van Leeuwenhoek Hospital
Emile E. Voest
Emile E. Voest Antoni van Leeuwenhoek Hospital
Jos Jonkers
Jos Jonkers Antoni van Leeuwenhoek Hospital
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering advancing your education in Biology, Biochemistry, or related fields, there are a variety of online degree and certification options to help accelerate your career. Students interested in health and nutrition can explore fast track nutrition degree online programs. These allow you to earn credentials quickly and efficiently, opening opportunities in dietetics, health education, or wellness coaching.

For those who wish to combine scientific training with business skills, an MBA in Healthcare Management may be a strong choice. Investigate the healthcare mba cost to find programs that fit both your budget and career ambitions, particularly if you’re aiming for leadership roles in the medical or biotechnological sectors.

Healthcare administration also offers certification pathways. If you are interested in medical coding, understanding the cpc vs ccs certification differences is crucial for choosing the right credential. Each certification prepares you for specific roles and salary prospects in medical billing and records management. For more information about earnings potential, see current medical.coder salary data to guide your career planning.

Best Scientists Citing Daniel S. Peeper

Trending Scientists

Recently Published Articles